Ibdenc

16/09/2026

🔰Cardiovascular safety in IBD treatment: New evidence suggests biologics & oral small molecules are not associated with increased major cardiovascular events or venous thromboembolism.

https://youtu.be/no440HR3yFM

Ibdenc

A large real-world study found that biologics and oral small molecu...

10/09/2026

🔰September 2026 IBD Journal – Editorial Recommendations

This month’s selection brings together five important publications offering fresh perspectives on ulcerative colitis treatment, precision IBD therapy, genetic risk, the evolving global burden of IBD, and C. difficile infection in IBD.

🔹 Updated ECCO guidelines for medical treatment of UC
🔹 Moving beyond drug-class effects towards drug-level precision
🔹 Cell-type-specific genetic insights into IBD risk
🔹 The changing IBD landscape across East & Southeast Asia
🔹 AGA guidance on managing C. difficile infection in IBD

Explore the latest evidence and insights shaping the future of IBD care.

🔗 Read more: www.ibdenc.org

29/08/2026

🔰KOL ROUND TABLE | MICROBIOME THERAPEUTICS & RESEARCH IN INDIA

“The future of microbiome science in India will be shaped not just by what we discover, but by the questions we choose to ask, and the way we come together to answer them.”

What if the future of microbiome science starts with asking better questions?

Leading experts came together to explore India-specific research, diagnostics, therapeutics, collaboration, access and ethics, and what it will take to turn microbiome science into meaningful healthcare impact.

One round table. Many perspectives. One shared opportunity for India.

Ibdenc

28/08/2026

🔰AIG Hospitals takes a pioneering step towards a new era of microbiome therapeutics.

Today, we inaugurate the AIG Microbiome Therapeutics & Pill Lab , A new platform created to translate the promise of microbiome science into possibilities for patient care.

The inauguration marked a gathering of distinguished clinical leaders and internationally recognised microbiome experts, including Dr D. Nageshwar Reddy, Chairman, AIG Hospitals; Dr G.V. Rao, Director, AIG Hospitals; Dr Rupa Banerjee, Director – IBD Centre; and internationally recognised microbiome experts Prof. Harry Sokol, Paris, and Prof. Michael Kamm, Australia.

With the ability to study the gut microbiome, translate its insights and explore oral microbiome-based therapeutics, the Lab creates a pathway from discovery to innovation, and innovation to patient care.

From microbes to medicine.
From discovery to possibility.
From possibility to patient care.

A NEW ERA OF MICROBIOME THERAPEUTICS BEGINS HERE.

Ibdenc

28/08/2026

What happens when we stop looking at the gut as just an organ, and start looking at it as an ecosystem?

That’s the conversation unfolding today at AIG Hospitals, at the ’AIG Gut Microbiome Masterclass: From Discovery to Therapeutics’ — bringing together leading voices in gastroenterology and microbiome science.
Trillions of microbes. One complex ecosystem.
And a growing understanding that they may influence far more than we once imagined.
From understanding the gut microbiome and its relationship with diet and lifestyle, to multi-omics, data interpretation, precision medicine, FMT and microbiome therapeutics, the conversation is moving steadily from discovery to clinical application.

And one thing is becoming increasingly clear:
The microbiome is not just part of the gut.
It could be part of the future of medicine.

Ibdenc

26/08/2026

From microbiome research to personalised medicine, explore the latest advances with leading national & international experts.
🔬 Multi-Omics | FMT | Microbiome Data | Precision Medicine | Therapeutics
✨ Inauguration of the AIG Microbiome Therapeutics & Pill Lab
📅 28 Aug 2026 | 9 AM–1 PM
📍 AIG Hospitals, Gachibowli, Hyderabad

Today is the last date for registration
👉 Register Now - https://event.aigacademics.com/

20/08/2026

Precision Nutrition: A Personalized Approach to Preventing and Managing Inflammatory Bowel Disease.

Ibdenc

As the global burden of inflammatory bowel disease (IBD) continues ...

10/08/2026

From microbiome research to personalised medicine, explore the latest advances with leading national & international experts.

🔬 Multi-Omics | FMT | Microbiome Data | Precision Medicine | Therapeutics

✨ Inauguration of the AIG Microbiome Therapeutics & Pill Lab

📅 28 Aug 2026 | 9 AM–1 PM
📍 AIG Hospitals, Gachibowli, Hyderabad

👉 Register Now - https://event.aigacademics.com/

05/08/2026

August 2026 | IBD Journal Highlights

Stay updated with the latest advances in inflammatory bowel disease (IBD) research featured in this month's Editorial Recommendations.

🔹 The Global Burden of Inflammatory Bowel Disease: From 2025 to 2045
🔹 Biologics and Oral Small Molecules Are Not Associated With Increased Major Adverse Cardiovascular Events or Venous Thromboembolism in Inflammatory Bowel Disease
🔹 Three-Year Efficacy and Safety of Mirikizumab Following 152 Weeks of Continuous Treatment for Ulcerative Colitis: Results From the LUCENT-3 Open-Label Extension Study
🔹 AI-enabled ‘Endo-Histo-Omics’: Breaking Down Intestinal Barriers in IBD
🔹 Why Symptoms Linger in Quiescent Crohn’s Disease: Investigating the Impact of Sulfidogenic Microbes and Sulfur Metabolic Pathways

Explore the latest evidence shaping the future of IBD care from global disease trends and long-term therapeutic outcomes to AI-driven precision medicine and microbiome research.

🌐 Read more: www.ibdenc.org

Ibdenc

25/07/2026

Does inflammatory bowel disease play a role in cognitive decline? A systematic review

Ibdenc

This systematic review examines the relationship between inflammato...